migraine

Specialty drug pipeline predictions: Seven key areas to watchThe specialty drugs market will see more approvals in 2017 than 2016. Top areas to watch include cancer, multiple sclerosis, and HIV.
Revisiting the migraine liftDespite two decades since its discovery, many patients may not be aware of the cosmetic surgery technique that offers permanent migraine relief.
Migraines in Women
Migraines in WomenThis article reviews how migraines in women are impacted by the fluctuating hormone levels they experience throughout their lifecycle.
Medication or placebo to prevent migraine?A trial comparing amitriptyline, topiramate, and placebo for prevention of migraine in children and adolescents with a history of migraine found that all 3 had about the same effect on reducing headache frequency or headache-related disability.
New dosage form for migraine treatmentFDA approved Onzetra Xsail (Avanir Pharmaceuticals Inc.)— a fast-acting, low-dose sumatriptan dry powder formulation for the acute treatment of migraine with or without aura in adults.
Impact of nutritional deficiencies on migrainesNutritional deficiencies may play a role in the development and/or perpetuation of migraines in children, according to a new study, but further research is needed to determine if supplementation would help.
‘Game changing’ migraine drugs on the horizonThere’s no silver bullet for migraine treatments, but treatments are getting more precise as we learn more about the cause of migraines.
Asking right questions leads to better headache diagnosisOphthalmologists can monitor the need for further headache evaluation and treatment with several simple question sets and a mnemonic.
Antithrombotic therapy to prevent migraine attacks after ASD closureClopidogrel therapy can make a difference after ASD closures.
Impact of menopause on migraine frequencyDo women suffer from more migraines as they transition into menopause? Plus: A report indicates that hospitals may not be adequately supporting breastfeeding in teenaged mothers. And, a look at prenatal exposure to bronchodilators and autism.